Purchase Order 75N94020P00863

Award Date 9/21/20
Potential Completion Date 12/31/20
Potential Value Not listed
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mayagüez, Puerto Rico
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to CDI Laboratories Inc. for $96,812.10. The contract is for the provision of 110 samples and bioinformatics analysis of serum samples using CDI's proprietary HuProt v4.0 protein arrays to support COVID-19 research. CDI Laboratories is a small disadvantaged business that has received numerous prime federal contracts from NIH...
This is a $98,253.09 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to CDI Laboratories Inc., a small disadvantaged business manufacturer. The contract is for the provision of CDI's HuProt v4.0 Human Proteome Microarray, containing over 21,000 human proteins, as well as its VirScan viral antibody profiling and immuneprofiler antibody analysis services. This work supports biomedical research efforts,...
This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to CD Biosciences Inc., doing business as Creative Biomart, for COVID-19 next-generation sequencing services. The $24,450.00 contract has a period of performance through September 20, 2022. CD Biosciences Inc. is a research product supplier and contract research organization that provides a wide range of specialized molecular biology services to federal agencies,...
This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to CDI Laboratories Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract, valued at $23,999.72, is for CDI Laboratories to provide its proprietary human proteome microarray assay services to support biomedical research efforts, particularly in the areas of infectious...
This is a $160,000 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Metabolon, Inc., a small disadvantaged business. The contract is for metabolomic profiling of 800 plasma biospecimens collected from COVID-19 patients and appropriate controls, in order to generate metabolic profiles to support research initiatives related to the coronavirus pandemic. The contract was awarded...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,592.25 firm fixed-price purchase order to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, for V-PLEX COVID-19 assay panel kits. This sole-source award, made without a set-aside, supports COVID-19 research conducted by the Ribonucleic Acid Viruses Section within the Laboratory of Infectious Diseases. The kits will be used to measure...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Acgt Inc., a small business, for $93,400.00. The contract is for COVID-19 research and includes services for premium DNA sequencing (11,400 units), PCR DNA column purification (11,600 units), and additional DNA sequencing (200 units). Acgt Inc. has previously provided similar services to NIAID and the Department of Agriculture's Animal and Plant Health Inspection Service....
This is a $20,600 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the Department of Health and Human Services, to Enamine US Inc., a small business contractor. The contract is for single-cell RNA sequencing analysis to investigate the role of GPR110 in cell-type specific neurogenesis. This award supports the NIAAA's mission in advancing translational science and developing prevention and treatment strategies...
This is a $97,106.08 firm fixed price purchase order award by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Virscidian Inc. for the renewal of a subscription to the Virscidian Analytical Studio Express - Instrument Agent software package. The award is non-competitive and was issued without full and open competition due to exclusive licensing agreements for this...
This firm fixed-price purchase order was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The $16,455.00 order is for the HU Immune Response 80PLEX 96 Tests product, a specialized reagent kit used in biomedical research and genetic analysis. The contract has no set-aside designation and is in support of NIAAA's...

This is a $120,000 firm fixed-price purchase order contract awarded by the National Institutes of Health's (NIH) National Institute on Alcohol Abuse and Alcoholism (NIAAA) to CDI Laboratories Inc. to provide their proprietary VirScan analysis service. The VirScan assay will allow NIAAA to determine if a subset of patients in their "COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study" were exposed to the virus causing COVID-19, as well as other viruses, which will provide unique insights into how heavy drinkers differ from the general population in their viral antibody profiles. This sole-source contract was awarded under simplified acquisition procedures, as only CDI Laboratories can provide this comprehensive viral profiling service. The contract has a completion date of December 31, 2020 and does not have a small business set-aside.

Generated 3/22/24, 11:35 PM